We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
XTRA:26CA
​
​
logo

ImmunityBio (26CA)

XTRA • 26CA • US45256X1037

7.36Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 21% of free float is sold short, 50,397.2 days to cover, cost to borrow 1%.

Market Cap

8.81b USD | # 1755 in DE

Volume

1.98k shares | 23.65k USD

Shares Outstanding

1.06b

Free Float Shares

38.37% | 406.69m

Nasdaq:IBRX|
DB:26CA

News

26CA key data

ImmunityBio (XTRA: 26CA) has a market capitalization of $8.81B. Last close €7.36 (as of 2026-11-04); 52-week range €5.79 to €9.59. ORTEX data as of 2026-11-03: short interest is 21% of free float, 50,397.2 days to cover and the average cost to borrow is 1%.

  • 26CA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.